
This is a CPD‑accredited, two‑part virtual CPD programme that delivers an authoritative update on evidence‑based breast‑cancer care for the contemporary African clinic. International experts in surgical, medical and radiation oncology, pathology, radiology, pharmacy, nursing and palliative care will guide participants through concise lectures, case‑based discussions and interactive decision tools. Core content spans tumour biology and molecular subtyping through to the practical sequencing of endocrine, targeted and systemic therapies, always integrating multidisciplinary perspectives and resource‑sensitive considerations. The course is expressly designed for oncologists, surgeons, pathologists, pharmacists, oncology nurses, primary‑care physicians and all other clinicians involved in breast‑cancer management across the disease continuum.
WHY YOU SHOULD ATTEND
1. Stay current – receive the latest consensus guidelines and emerging data on molecular diagnostics, endocrine resistance, targeted therapy and survivorship.
2. Multidisciplinary insights – learn how surgeons, oncologists, pathologists, pharmacists and nurses coordinate to deliver seamless, patient‑centred care.
3. African relevance – faculty place every recommendation in the context of local epidemiology, resource availability and practice realities.
4. Practical skills – work through real pathology reports, genomic assay results and treatment algorithms you can apply the very next clinic day.
5. Interactive learning – audience polling, breakout case workshops and live Q&A foster active engagement rather than passive listening.
6. CPD credit – earn recognised CME/CPD points to meet professional‑licensing requirements.
EVENT HIGHLIGHTS
1. Real‑time case‑solving workshops with voting on therapeutic choices and faculty feedback
2. Pathology and genomic assay master‑class: interpreting ER/PR/HER2/BRCA/Ki‑67 and multigene signatures
3. Therapy‑sequencing simulation for hormone‑receptor‑positive and HER2‑low tumours
4. Panel debate on managing endocrine resistance and metastatic disease in resource‑limited settings
5. Supportive‑care segment covering symptom control, fertility, psychosocial and palliative integration
6. Dedicated pharmacy and nursing breakout on safe handling of novel agents and patient counselling
SUMMARY OF TOPICS
i. Foundations of Breast‑Cancer Biology and Pathology
ii. Hormone‑Receptor‑Positive Disease
iii. Precision Medicine & Targeted Therapies (Series Part 2)
iv. Multidisciplinary & Supportive Care
v. Practical Implementation in African Settings
PARTICIPANT CONSENT AND DATA PRIVACY NOTICE
By registering for Precision in Breast Cancer Management: A Multidisciplinary Update for Modern Oncology Practice, you consent to participate in this training hosted by Continuous Education Services (CES). Registration information will be used solely to administer the event and to secure CPD accreditation through the Various Council. CES is committed to protecting your personal data and will not share personally identifiable information with any commercial partner or sponsor. Data will be disclosed only to the councils or other relevant regulatory bodies for the single purpose of assigning CPD points earned. You may withdraw from the meeting at any time; if you choose to do so, no further action is required. Your privacy and confidentiality are assured at every stage of the process.
ORGANIZED BY
PROUDLY SPONSORED BY
This will be a virtual event. It will be streamed LIVE on this page.
Date: Tue, the 5th August 2025
Time: 14:00 - 1600 GMT (2:00- 6:30 pm Local Time)
Target Participants: Medical Doctors, Pharmacists, Nurses and Midwives, Allied Health Professionals.
The agenda is available to download in the downloads section.
This CME‑accredited virtual CPD programme brings together an international, multidisciplinary faculty to deliver a concise two‑part update on contemporary breast‑cancer care, blending evidence‑based lectures with interactive case workshops tailored to the African clinical landscape; participants will explore tumour biology, molecular sub‑typing, endocrine and targeted‑therapy sequencing, management of resistance, supportive and palliative measures, and resource‑sensitive implementation strategies—ultimately equipping oncologists, surgeons, pathologists, pharmacists, nurses and primary‑care clinicians with the practical knowledge and collaborative skills required for truly personalised, patient‑centred management across the disease continuum.
By the end of the programme, participants will be able to:
1. Describe the molecular and pathological basis of breast cancer and relate subtypes to prognosis and treatment.
2. Interpret genomic assays and standard pathology reports to individualise therapy.
3. Apply current evidence based guidelines for hormone receptor positive disease, including sequencing of endocrine and targeted agents.
4. Identify and manage mechanisms of therapeutic resistance and adjust treatment plans accordingly.
5. Integrate multidisciplinary and supportive care strategies across all stages, from diagnosis to survivorship and palliation.
6. Adapt precision medicine principles to varying resource levels within African clinical practice.
BSc, MB ChB, FWACS, FGCS
Senior Lecturer
Consultant General Surgeon
University of Ghana Medical School
Korle Bu Teaching Hospital
Dr. Josephine Nsaful is a Consultant General Surgeon and Senior Lecturer at the University of Ghana Medical School and Korle-Bu Teaching Hospital.
View full profile / coursesBSc, MBChB, MGCPS, FWACP
Associate Professor of Anatomic Pathology
University of Cape Coast, Cape Coast, Ghana.
Prof. Patrick Kafui Akakpo is an Associate Professor of Anatomic Pathology at the School of Medical Sciences, University of Cape Coast, where he also heads the Department of Pathology.
View full profile / coursesBSc; MB, ChB., FGCP
Senior Specialist Radiation/ Clinical Oncology
National Radiotherapy Oncology & Nuclear Medicine Centre. Korle-Bu Teaching Hospital. Accra, Ghana, WA
View full profile / coursesBSc, MB CHB, MGCPS
Specialist Radiation Oncologist
National Center for Radiotherapy and Nuclear Medicine
Dr. Naa Adorkor Aryeetey is a dedicated Specialist Radiation Oncologist affiliated with the National Center for Radiotherapy and Nuclear Medicine. With a passion for addressing the evolving healthcare landscape in Ghana, Dr.
View full profile / coursesBA, BA Hons, MSc(Med)
Genetic Counsellor
West African Genetic Medicine Centre, University of Ghana | Project Coordinator for the HI‑Genes Africa Research Rnitiative
Kalinka Tavares is a South African genetic counsellor registered with the Health Professions Council of South Africa who currently serves at the West African Genetic Medicine Centre, University of Ghana.
View full profile / coursesBSc, MBChB, MGCP
Clinical Oncologist (Radiation and Medical Oncology)
National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital in Accra.
Dr Nana Ama Kuntuah Wadee is a clinical oncologist at the National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, where she delivers personalised radiotherapy, chemotherapy and targeted‑therapy plans and chairs multidisciplinary discussions to optimise patient outcomes.
View full profile / coursesDr. Edward Bright Agyekum , Mrs. Araba Kudiabor , Dr. Stephen Ayisi Addo , Dr. Jacob Kuutuome , Dr. Kwadwo Koduah Owusu , Dr. Gifty Dede Mateko Angmor , Dr. Catherine Armah
Dr. John Humphrey Amuasi , Dr. (Mrs.) Adwoa Bemah Boamah Mensah , Dr. Yeetey Akpe Kwesi Enuameh , Dr. Joseph Bonney , Dr. Kofi Boamah Mensah , Dr. Joshua Appiah Arthur , Dr. Ijeoma Chinedum Anyitey-Kokor , Dr. Anthony Afum-Adjei Awuah , Dr Laud Anthony Wihibeturo Basing , Mr. Louis Adu-Amoah
Dr. Patrick Kuma-Aboagye , Dr. Franklin Asiedu-Bekoe , Dr. Stephen Ayisi Addo , Dr. Kwadwo Koduah Owusu , Dr. Raphael Adu-Gyamfi , Caroline Adonadaga